Bristol-Myers Squibb Company PFD CONV 2 BMYMP OTC

Other OTC • Healthcare • Drug Manufacturers - General • US • USD

共有 50 笔近期内部人交易记录记录，涉及 Bristol-Myers Squibb Company PFD CONV 2 (BMYMP), 包括 32 笔买入 和 16 笔卖出. 内部人买入总额为 $1.15M 内部人卖出总额为 $4.7M.

近期活跃的重要内部人包括 Poole Ahn Amanda, Storch Gerald L, Yale Phyllis R. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — BMYMP

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2024-01-01	Poole Ahn Amanda	EVP, Chief Human Resources	处置	4,822	-	-	-
2023-12-31	Storch Gerald L	Director	限制性股票授予 (RSU)	706	-	-	82,140
2023-12-31	Yale Phyllis R	Director	限制性股票授予 (RSU)	658	-	-	22,359
2023-12-31	Arduini Peter J	Director	限制性股票授予 (RSU)	658	-	-	47,167
2023-12-31	Rice Derica W	Director	限制性股票授予 (RSU)	706	-	-	18,401
2023-12-31	Haller Julia A	Director	限制性股票授予 (RSU)	706	-	-	22,746
2023-12-31	Samuels Theodore R. Ii	Director	限制性股票授予 (RSU)	950	-	-	42,103
2023-12-31	Hidalgo Medina Manuel	Director	限制性股票授予 (RSU)	164	-	-	9,188
2023-12-31	Bhatt Deepak	Director	限制性股票授予 (RSU)	164	-	-	5,506
2023-12-15	Hoch Lynelle	President, Cell Therapy Org.	处置	6,304	-	-	-
2023-12-05	Boerner Christopher S.	Chief Executive Officer	知情买入	2,000	$49.78	$99.56K	82,672
2023-12-02	Elkins David V	EVP, Chief Financial Officer	期权行权（卖出）	8,792	-	-	-
2023-12-02	Boerner Christopher S.	Chief Executive Officer	期权行权（卖出）	2,638	-	-	-
2023-12-02	Plenge Robert M	EVP, Chief Research Officer	期权行权（卖出）	616	-	-	-
2023-11-28	Boerner Christopher S.	Chief Executive Officer	知情买入	3,071	$48.86	$150.05K	79,384
2023-11-21	Leung Sandra	EVP, General Counsel	其他（买入）	9,830	$48.75	$479.16K	93,436
2023-11-20	Samuels Theodore R. Ii	Director	知情买入	8,500	$49.81	$423.39K	35,500
2023-11-01	Boerner Christopher S.	Chief Executive Officer	限制性股票授予 (RSU)	11,858	-	-	11,858
2023-10-10	Caforio Giovanni	Board Chair and CEO	赠与（送出）	440	-	-	367,495
2023-10-02	Gallman Cari	EVP, Corporate Affairs	处置	5,201	-	-	-
2023-10-02	Gallman Cari	EVP, Corporate Affairs	限制性股票授予 (RSU)	13,675	-	-	13,675
2023-09-30	Storch Gerald L	Director	限制性股票授予 (RSU)	625	-	-	80,538
2023-09-30	Yale Phyllis R	Director	限制性股票授予 (RSU)	581	-	-	21,463
2023-09-30	Arduini Peter J	Director	限制性股票授予 (RSU)	581	-	-	45,998
2023-09-30	Rice Derica W	Director	限制性股票授予 (RSU)	625	-	-	17,500
2023-09-30	Haller Julia A	Director	限制性股票授予 (RSU)	625	-	-	21,797
2023-09-30	Samuels Theodore R. Ii	Director	限制性股票授予 (RSU)	840	-	-	40,701
2023-09-30	Bhatt Deepak	Director	限制性股票授予 (RSU)	145	-	-	5,283
2023-08-24	Powell Ann	EVP, Chief Human Resources	知情卖出	17,986	$61.25	$1.1M	27,868
2023-08-03	Plenge Robert M	EVP, Chief Research Officer	知情卖出	732	$61.14	$44.75K	6,584
2023-07-03	Plenge Robert M	EVP, Chief Research Officer	处置	14,052	-	-	-
2023-07-01	Hirawat Samit	EVP,chief Med.offr.,drug Dev.	期权行权（卖出）	9,357	-	-	-
2023-07-01	Weese Michelle	EVP, Corporate Affairs	RSU 预扣税	682	$63.95	$43.61K	3,453
2023-06-30	Storch Gerald L	Director	限制性股票授予 (RSU)	567	-	-	79,180
2023-06-30	Yale Phyllis R	Director	限制性股票授予 (RSU)	528	-	-	20,690
2023-06-30	Arduini Peter J	Director	限制性股票授予 (RSU)	528	-	-	45,000
2023-06-30	Rice Derica W	Director	限制性股票授予 (RSU)	567	-	-	16,721
2023-06-30	Haller Julia A	Director	限制性股票授予 (RSU)	554	-	-	20,978
2023-06-30	Samuels Theodore R. Ii	Director	限制性股票授予 (RSU)	762	-	-	39,495
2023-06-30	Bhatt Deepak	Director	限制性股票授予 (RSU)	127	-	-	5,091
2023-06-03	Lenkowsky Adam	EVP, Chief Commercial Officer	期权行权（卖出）	1,077	-	-	-
2023-05-03	Vessey Rupert	EVP & President, Research	知情卖出	50,385	$67.06	$3.38M	47,751
2023-05-02	Greenlees Sharon	SVP & Controller	RSU 预扣税	227	$68.10	$15.46K	400
2023-05-01	Lenkowsky Adam	EVP, Chief Commercial Officer	限制性股票授予 (RSU)	5,494	-	-	5,494
2023-04-26	Lenkowsky Adam	EVP, Chief Commercial Officer	未知	3,580	-	-	-
2023-04-01	Mily Elizabeth	EVP, Strategy & Bd	期权行权（卖出）	2,684	-	-	2,685
2023-04-01	Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	RSU 预扣税	1,692	$69.31	$117.27K	3,226
2023-03-31	Storch Gerald L	Director	限制性股票授予 (RSU)	523	-	-	77,963
2023-03-31	Yale Phyllis R	Director	限制性股票授予 (RSU)	487	-	-	19,996
2023-03-31	Arduini Peter J	Director	限制性股票授予 (RSU)	487	-	-	44,104